Meng-Yun Chou

发表

Oxidation‐specific epitopes are important targets of innate immunity

J. Witztum, P. Shaw, C. Binder, 2008, Journal of internal medicine.

Collective action of hematopoietic cell subsets mediates anti-IL10R1 and CpG tumor immunity

J. Kim, Cary D. Austin, Meng-Yun Chou, 2012, Cancer Immunology, Immunotherapy.

Deficiency of antigen-presenting cell invariant chain reduces atherosclerosis in mice.

P. Libby, H. Ploegh, J. George, 2009, Circulation.

Oxidation-specific epitopes are targets of innate natural antibodies : potential implications in health and disease

Meng-Yun Chou, 2009 .

The role of innate immunity in atherogenesis11 Guest editor for this article was Linda Curtiss, the Scripps Research Institute. Published, JLR Papers in Press, December 22, 2008.

J. Witztum, P. Shaw, S. Tsimikas, 2009, Journal of Lipid Research.

Oxidation-specific epitopes are dominant targets of innate natural antibodies in mice and humans.

F. Bäckhed, J. Witztum, M. Corr, 2009, The Journal of clinical investigation.

Development of phospho-specific Rab protein antibodies to monitor in vivo activity of the LRRK2 Parkinson's disease kinase

M. Mann, J. Holton, D. Alessi, 2017, The Biochemical journal.

University of Dundee Development of phospho-specific Rab protein antibodies to monitor in vivo activity of the LRRK 2 Parkinson ’ s disease kinase

M. Mann, J. Holton, D. Alessi, 2017 .

Title Development of phospho-specific Rab protein antibodies tomonitor in vivo activity of the LRRK 2 Parkinson ' s disease kinase

M. Mann, J. Holton, D. Alessi, 2017 .

Human oxidation-specific antibodies reduce foam cell formation and atherosclerosis progression.

Andrew C. Li, G. Getz, T. Friedmann, 2011, Journal of the American College of Cardiology.

Natural antibodies in murine atherosclerosis.

J. Witztum, P. Shaw, C. Binder, 2008, Current drug targets.

University of Dundee The Parkinson's disease VPS35[D620N] mutation enhances LRRK2 mediated Rab protein phosphorylation in mouse and human Mir,

D. Alessi, I. Milenkovic, T. Brücke, 2018 .

Atheroprotective immunization with malondialdehyde-modified LDL is hapten specific and dependent on advanced MDA adducts: implications for development of an atheroprotective vaccine1[S]

D. Tsiantoulas, J. Witztum, M. VanNieuwenhze, 2014, Journal of Lipid Research.

The Parkinson's disease VPS35[D620N] mutation enhances LRRK2-mediated Rab protein phosphorylation in mouse and human

D. Alessi, Terina N. Martinez, I. Milenkovic, 2018, The Biochemical journal.

A Cis-spreading Nucleoprotein Filament Is Responsible for the Gene Silencing Activity Found in the Promoter Relay Mechanism*

Chien-Chung Chen, Chun-Hao Huang, A. Majumder, 2005, Journal of Biological Chemistry.

Research resource: Comparative nuclear receptor atlas: basal and activated peritoneal B-1 and B-2 cells.

C. Glass, R. Evans, G. Barish, 2011, Molecular endocrinology.

Oxidation-specific epitopes are dominant targets of innate natural antibodies in mice and humans.

F. Bäckhed, J. Witztum, M. Corr, 2009, The Journal of clinical investigation.

The role of innate immunity in atherogenesis11 Guest editor for this article was Linda Curtiss, the Scripps Research Institute. Published, JLR Papers in Press, December 22, 2008.

J. Witztum, P. Shaw, S. Tsimikas, 2009, Journal of Lipid Research.